Article

AlphaRx adds Dr. Berlin to scientific advisory board

Markham, Ontario, Canada-AlphaRx Inc. announced the appointment of Michael S. Berlin, MD, MS, to its scientific advisory board.

Dr. Berlin is currently a clinical professor at the Jules Stein Eye Institute, University of California, Los Angeles. He is a member of the American Academy of Ophthalmology, the American Glaucoma Society, and the American Society for Laser Medicine and Surgery. He has researched and published numerous books and articles on glaucoma and laser surgery, and he is regularly invited to lecture at professional conferences, both in the United States and internationally.

Dr. Berlin also is the founder and director of the Glaucoma Institute-Beverly Hills, and he is a board-certified ophthalmologist specializing in laser surgery and in the research and treatment of glaucoma.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
© 2025 MJH Life Sciences

All rights reserved.